Indegene Explained

Indegene Limited
Former Name:Indegene Lifesystems Private Limited (1998–2016)
Indegene Private Limited (2016–2022)
Type:Public
Industry:Pharmaceutical consultancy[1]
Founders:Rajesh Nair
Manish Gupta
Sanjay Parikh
Anand Kiran
Gaurav Kapoor
Location City:Bangalore
Location Country:India
Area Served:Worldwide
Key People:Manish Gupta (CEO)[2]
Revenue: (FY24)
Operating Income: (FY24)
Net Income: (FY24)[3]
Num Employees:5,081 (March 2024)

Indegene Limited is an Indian company that provides research and commercialization services to biopharmaceutical and healthcare enterprises.[4] [5] [6] Based in Bangalore, the company provides consulting in pharmaceutical marketing, clinical trials, pharmacovigilance, medical and regulatory affairs, and health informatics.[7] [8]

History

Indegene was founded in 1998 by Dr. Rajesh Nair, Manish Gupta, Gaurav Kapoor, Dr.Sanjay Parikh and Anand Kiran.[9] Indegene's first acquisition was Medsn, a company that provided medical education. Medsn continued to operate under the same name in the United States.[10] In 2008, Medsn officially became Indegene Pharmaceutical Solutions in the United States. In 2006, Indegene acquired MedCases, a continuing medical education company based in the United States.[6]

In 2009, Indegene signed a master service agreement with six pharmaceutical companies.[5] [11] The following year, Indegene acquired Canada-based Aptilon, a multichannel marketing firm, for $4 million.[12] The company subsequently acquired Atlanta-based Total Therapeutic Management in 2014.[13]

In September 2019, Indegene acquired London-based consulting company, DT Associates, for $10 million.[14]

In February 2021, the Carlyle Group and Brighton Park Capital invested $200 million in Indegene.[15] In August 2021, Indegene acquired Medical Marketing Economics (MME), an American market access and pricing strategy company, for $10 million.[16]

Indegene went public in May 2024 with an initial public offering, raising . It listed on the BSE and the NSE.[17]

Operations

Indegene has offices in India, the United States, the European Union, and Asia-Pacific.[18] [19]

In 2011 and 2012, The Economic Times named Indegene one of the best companies to work for in the Professional Services industry.[20]

Notes and References

  1. Web site: Indegene ends 26% higher on listing day . 13 May 2024 .
  2. News: Indegene on the prowl for global acquisitions . 8 January 2023 . The Hindu Businessline . 12 August 2020 . en.
  3. Web site: Fact Sheet – Q4 FY2024 . Indegene . 30 May 2024.
  4. News: Das. Avik. Flipkart, Practo CEOs get top rating from staff. The Economic Times. 2 September 2015 . 2 October 2015.
  5. News: Singh. Seema. Cutting pharma costs by intelligent marketing. Mint. 7 May 2009 . 2 October 2015.
  6. News: Unnikrishnan. CH. Indegene buys US firm. Business Standard. 8 November 2006 . 2 October 2015.
  7. News: Murayama. Keiichi. India's tech muscle has the world's attention . The Nikkei. 19 February 2015 . 2 October 2015.
  8. News: Indegene files papers with Sebi; eyes ₹3,200 crore via IPO . 8 January 2023 . mint . 15 December 2022 . en.
  9. News: Amirapu. Deepika. Indegene eyes US call centre buy for $10–15 million. The Economic Times. 9 March 2012 . 2 October 2015.
  10. News: D'Silva. Jeetha. Indegene acquires US medical education co. The Economic Times. 17 September 2005 . 2 October 2015.
  11. News: Indegene highlights benefits of patient adherence programs for pharma cos . PharmaBiz. 3 June 2011 . 2 October 2015.
  12. News: Mukherjee. Rupali. Indegene to acquire Canada-based company for $4 million . Times of India. 7 November 2012 . 2 October 2015.
  13. News: Craig. Tara. Indegene acquires Total Therapeutic Management . PMLive.com. 9 January 2014 . 2 October 2015.
  14. News: Balakrishnan . Reghu . Healthcare tech firm Indegene acquires DT Associates . 28 April 2024 . The Economic Times . 3 September 2019.
  15. News: Madhurima. Nandy. Indegene to raise $200 mn from Carlyle, Brighton Park. LiveMint. 3 February 2021 . 20 August 2021.
  16. News: Baruah . Ayushman . Indegene acquires US-based Medical Marketing Economics for $10 mn . 28 April 2024 . Mint . 30 August 2021 . en.
  17. News: Narayanan . KS Badri . Indegene IPO opens today in ₹430-452 price band . 6 May 2024 . BusinessLine . 6 May 2024 . en.
  18. News: Vijay. Nandita. Indegene plans next phase of growth through acquisition in US, EU markets . PharmaBiz. 7 November 2012 . 2 October 2015.
  19. News: Indegene acquires MedCases, LLC. NFV Zone. 30 November 2006 . 2 October 2015.
  20. News: Best companies to work for 2012: Companies that came up trumps across various sectors. The Economic Times. 16 July 2012 . 2 October 2015.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Indegene".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.